Month 9 Plateau
The month 9 stall is different from earlier ones — it often signals you're approaching your individual plateau weight rather than just needing another dose bump. Here's how to read it.
The short answer
By month 9 on a GLP-1, the average curve from the major trials (STEP 1 with semaglutide, SURMOUNT-1 with tirzepatide) is clearly bending toward a plateau. Most weight loss happens by month 12-16, then stabilizes. If you've stalled at month 9, the questions become: are you at your max dose, are you near your individual plateau, and is now the moment to shift mindset from "losing" to "maintaining and recomposing"? For many people, month 9 is when the work pivots from dose-driven loss to muscle-driven recomposition.
What to know
The STEP 1 trial showed average weight loss of about 15% over 68 weeks of semaglutide, with the curve clearly flattening between weeks 40 and 68 (roughly months 9-16). SURMOUNT-1 showed average 20-22% loss over 72 weeks of tirzepatide with a similar deceleration in the back half. This means a month 9 stall is statistically expected — you've captured most of the loss the medication will produce, and the next 3-6 months may yield smaller, slower decreases.
That said, "average" hides huge individual variation. Some people lose for 18 months. Others reach their personal floor at month 8. The honest assessment at month 9 is: are you happy with where you are? If yes, the conversation shifts to maintenance — what dose keeps the appetite signal in place, what habits hold the weight, what does the next 5 years look like. If no, the conversation is about whether more medication time will help, whether a switch (e.g., semaglutide to tirzepatide) is warranted, and whether the bottleneck is now lifestyle rather than pharmacology.
The other thing that happens around month 9 is body composition becomes visible. Up to this point, the scale moves fast and you mostly track weight. Now the scale slows and you start noticing what's actually under the clothes — and many people realize they want to recomp more than they want to keep losing scale weight. Strength training, protein, and time become the levers, not another titration.
Reading the month 9 signal
Compare to trial curves
If you've lost 15-25% of starting weight, you're tracking with or ahead of trial averages. Continued loss is possible but slower from here.
Shift to recomposition
Protein at 0.8-1.0 g per lb of goal weight + resistance training 3-4x per week is what changes the body when the scale stops moving.
Talk maintenance dose
Some people stay on a maintenance dose long-term; some taper. Have the conversation with your prescriber about what the next year looks like.
Common questions
Common Concerns
How do I know if this is my real plateau or a temporary stall?expand_more
Should I switch from semaglutide to tirzepatide if I'm stalled at month 9?expand_more
Can I stay on a GLP-1 forever to keep losing?expand_more
What if I want to stop here at month 9?expand_more
Is loss possible past month 9?expand_more
Keep exploring
Browse all GLP-1 guides.